Avelumab maintenance (urothelial post-platinum chemo)

Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.

Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.

Source YAML: complete record

Components	`DRUG-AVELUMAB`

ID	`REG-AVELUMAB-MAINTENANCE`
Type	Regimen
Status	pending_clinical_signoff
Diseases	None declared
Sources	`SRC-NCCN-BLADDER-2025`

Notes

JAVELIN Bladder 100: median OS 21.4 vs 14.3 months (BSC).

Used By

Indication

IND-UROTHELIAL-METASTATIC-1L-PLATINUM-CHEMO-AVELUMAB - IND-UROTHELIAL-METASTATIC-1L-PLATINUM-CHEMO-AVELUMAB